Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.4B | 10.9B | 10.6B | 11.0B |
Cost of revenue | 9.0B | 10.3B | 10.0B | 10.3B |
Gross profit | 428.2M | 627.7M | 597.0M | 733.5M |
Operating expense | ||||
Research & development | 184.5M | 243.2M | 217.0M | 277.6M |
Selling general and admin | 68.9M | -85.2M | 154.4M | -14.2M |
Other operating expenses | 17.0M | 25.1M | 18.9M | 21.0M |
Operating income | 194.3M | 319.7M | 313.4M | 381.1M |
Non operating interest income | ||||
Income | 5.5M | 10.1M | -5.7M | 12.5M |
Expense | 28.4M | 87.1M | 36.6M | -4.0M |
Other income expense | — | — | — | — |
Pretax income | 150.7M | 269.5M | 263.2M | 442.1M |
Tax provision | 30.8M | 43.8M | 53.3M | 79.6M |
Net income | 119.9M | 225.7M | 209.9M | 362.5M |
Basic EPS | 0.3 | — | — | — |
Diluted EPS | 0.3 | — | — | — |
Basic average shares | 370.0M | — | — | — |
Diluted average shares | 370.0M | — | — | — |
EBITDA | 187.7M | 374.7M | 334.0M | 332.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | -16.3M | -4.4M | -53.8M | -57.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |